US 10220082
WT1 vaccine
granted A61KA61K2039/53A61K39/0011
Quick answer
US patent 10220082 (WT1 vaccine) held by Inovio Pharmaceuticals, Inc. expires Mon Feb 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Inovio Pharmaceuticals, Inc.
- Grant date
- Tue Mar 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 32
- CPC classes
- A61K, A61K2039/53, A61K39/0011, A61K39/001153, A61P